Abiomed Inc.
Danvers, MA
- UEI
- KBGSE7HJSDE3
- CAGE
- 1LH63
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Johnson & Johnson, ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 22 Cherry Hill Dr, Danvers, MA 01923, USA
- Website
- abiomed.com
- Founded
- 1981
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $1,143,332 |
| FY2025 | $1,085,789 |
| FY2024 | $6,487,819 |
| FY2023 | $8,289,813 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $1,076,682 | |
| 2 | Defense Health Agency | $66,650 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Johns Hopkins University | N660012424024 | $510,144 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| T C V S | Ann Arbor, MI | 339112 Surgical and Medical Instrument Manufacturing |
| Endologix LLC | Santa Rosa, CA | 339113 Surgical Appliance and Supplies Manufacturing |
| Zoll Respicardia Inc. | Hopkins, MN | 339112 Surgical and Medical Instrument Manufacturing |
| Edwards Lifesciences Corporation | — | — |
| Boston Scientific Corp | Marlborough, MA | 339112 Surgical and Medical Instrument Manufacturing |
About the company
Abiomed Inc., a medical device manufacturer headquartered in Danvers, Massachusetts, delivers Impella percutaneous cardiac support devices—including heart pumps, catheters, controllers, and associated maintenance and repair services—almost exclusively to federal healthcare agencies as a prime contractor on full-and-open procurements with no set-aside activity.
The company's federal footprint centers on the Department of Veterans Affairs, which accounts for the vast majority of awards across 23 Veterans Integrated Service Networks. The top five VA customers by combined potential value—VISN 12, VISN 22, VISN 17, VISN 8, and VISN 16—represent 65% of all dollars across the recent award base of $241.2 million. By award count, VISN 17 leads with 116 awards ($18.3 million combined potential value), followed by VISN 22 with 107 awards ($46.6 million), and VISN 10 with 95 awards ($5.1 million). The Department of the Army Medical Command, Defense Health Agency, and Defense Logistics Agency constitute the remainder of Abiomed's federal customer base. Across all 36 distinct customer agencies, 1,590 total awards span contract types ranging from single purchase orders for emergency Impella devices (valued at $25 thousand to $100 thousand) to large delivery orders and indefinite-delivery contracts anchoring multi-year maintenance relationships.
Abiomed's work is rooted in original-equipment-manufacturer (OEM) exclusivity. The company holds a GSA Medical Equipment and Supplies Schedule contract (FSS-65-II-A) through which 846 task orders have been placed, generating $159.2 million in combined potential value. Additional indefinite-delivery contracts with individual VISNs—including a single-award IDIQ with VISN 4 for preventative maintenance and repair of Impella balloon pumps (ceiling $242.5 thousand, completion June 2029), an IDIQ with VISN 17 for service agreements and Impella coverage (ceiling $238.6 thousand, completion July 2029), and a blanket purchase agreement with VISN 16 for Impella pump sets (ceiling $1.13 million, ultimate completion January 2024)—cement recurring procurement patterns. Abiomed's sole-source justifications consistently cite exclusive authorization to service proprietary Impella diagnostic software and calibration tools unavailable to competitors, supported by FAR 6.302-1 authority. Recent representative work includes a $291 thousand maintenance contract with VISN 12 for six Abiomed cardiac support machines at three Milwaukee VA facilities (completion April 2030), a $410 thousand purchase order from VISN 17 for Impella 5.5 devices with SmartAssist (December 2023), and a $850.3 million delivery order from VISN 7 for Impella pump sets (completion February 2028).
Abiomed competes entirely outside set-asides and participates in no visible subcontracting footprint; the source identifies only one grant sub-award, a Johns Hopkins University-led IRONMAN project focused on novel extracorporeal membrane oxygenation (ECMO) support. The vendor's NAICS concentration—919 awards under Surgical and Medical Instrument Manufacturing, 230 under Electromedical and Electrotherapeutic Apparatus Manufacturing—reflects its posture as a specialized device supplier rather than a services or systems integration firm. Award velocity averaged 81 per year over 2022–2024 but has decelerated sharply to 27 annualized awards in 2025–2026, a contraction linked to the maturation of the VA's Impella procurement base and reduced emergency procurement frequency. Within the next twenty-four months, 21 awards carrying combined potential value of $2.8 million approach completion and face recompete or renewal, a modest cliff relative to the $241.2 million total portfolio. The company's federal revenue footprint is heavily weighted toward maintenance-of-service, replacement-parts, and device-supply work; no turnkey engineering, system integration, or consulting capabilities surface in the award record.
Quick answers
Is Abiomed Inc. registered in SAM.gov?
Yes. Abiomed Inc.'s SAM.gov registration is active through December 16, 2026.
Which contract vehicles does Abiomed Inc. hold?
Abiomed Inc. holds a place on 1 federal contract vehicle: FSS-65-II-A.
How much has Abiomed Inc. received in federal contracts?
Federal contracts obligated $1,085,789 to Abiomed Inc. in fiscal year 2025 and $17,006,754 in fiscal years 2023 through 2027.
How does Abiomed Inc. rank among federal contractors?
Abiomed Inc.'s parent company, Johnson & Johnson, ranked #58 in NAICS 339112, #59 in PSC J065 and #95 in NAICS 811219 in FY2025.
What is Abiomed Inc.'s most recent federal award?
Abiomed Inc.'s most recent federal contract award is Impella maintenance for RMR (36C25926P0478), from Veterans Integrated Service Network 19 (VHA), on September 30, 2026.
On GovTribe
See Abiomed Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors